Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models
- PMID: 16447208
- DOI: 10.1002/lt.20700
Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models
Abstract
Living donors represent a recognized alternative for facilitating the access to transplantation in a period of organ shortage. However, which candidates should be preferentially considered for living-donor liver transplantation (LDLT) is debated. The aim of this study was to create statistical models to determine which strategies of selection for LDLT provide the most efficient contribution. The study included 331 patients listed for deceased-donor transplantation (DDLT) and 128 transplanted with living donors. Statistical models predicting the events following listing were created and combined in a multistate model allowing the testing of different strategies of selection for LDLT and to compare their results. Taking 3-yr survival after listing as the principal end-point, selecting the 20% patients at highest risk of death on the waiting list gave better results than selecting the 20% patients at lowest risk of death after LDLT (70% vs. 64%, respectively). These strategies resulted in waiting list mortality rates of 17% and 8%, respectively. One-year survival after LDLT was lower in high-risk patients (85%) than in low-risk patients (91%). However, the 1-yr survival benefit derived from LDLT was 75% in high-risk patients while it was nil in low-risk patients. In conclusion, LDLT is more effective for overcoming the consequences of organ shortage when performed in patients at high risk of death on the waiting list. On an individual basis, the sickest patients are those who derive the most important benefit from LDLT. This study provides incentives for considering LDLT in high-risk patients.
Copyright 2006 AASLD
Similar articles
-
Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.Liver Transpl. 2004 Oct;10(10):1263-8. doi: 10.1002/lt.20254. Liver Transpl. 2004. PMID: 15376301
-
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.Liver Transpl. 2003 Jul;9(7):737-40. doi: 10.1053/jlts.2003.50122. Liver Transpl. 2003. PMID: 12827562
-
The role and limitation of living donor liver transplantation for hepatocellular carcinoma.Liver Transpl. 2004 Mar;10(3):440-7. doi: 10.1002/lt.20097. Liver Transpl. 2004. PMID: 15004774
-
Does living donation have advantages over deceased donation in liver transplantation?J Gastroenterol Hepatol. 2010 Oct;25(10):1598-603. doi: 10.1111/j.1440-1746.2010.06418.x. J Gastroenterol Hepatol. 2010. PMID: 20880167 Review.
-
Living donor liver transplantation.Curr Opin Organ Transplant. 2010 Jun;15(3):283-7. doi: 10.1097/MOT.0b013e32833983ee. Curr Opin Organ Transplant. 2010. PMID: 20489627 Review.
Cited by
-
Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation.Turk J Gastroenterol. 2020 Nov;31(11):782-789. doi: 10.5152/tjg.2020.18761. Turk J Gastroenterol. 2020. PMID: 33361041 Free PMC article.
-
Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular Carcinoma.Liver Cancer. 2013 Aug;2(3-4):332-7. doi: 10.1159/000343848. Liver Cancer. 2013. PMID: 24400220 Free PMC article.
-
Adult to adult living related liver transplantation: where do we currently stand?World J Gastroenterol. 2012 Dec 14;18(46):6729-36. doi: 10.3748/wjg.v18.i46.6729. World J Gastroenterol. 2012. PMID: 23239910 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical